Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- National University of Singapore
- University College Cork
- University of Michigan
- University of Nebraska–Lincoln
- Arizona State University
- Case Western Reserve University
- Drexel University
- IBEC
- INSERM
- McGowan Institute
- NIST
- Universidad Europea Miguel de Cervantes
- University of British Columbia
- University of California, Los Angeles
- University of Kansas
- University of Kansas Medical Center
- University of Maryland, Baltimore
- 7 more »
- « less
-
Field
-
Biomaterials Division opportunity location 50.64.41.B7206 Gaithersburg, MD NIST only participates in the February and August reviews. Advisers name email phone David J. Ross [email protected] 301.975.2525
-
) to identify, engineer, and leverage the role of confinement in cell biology. It is interested in leveraging new molecular biology tools, including RNA-Seq, CRISPR screens, ChIP-seq, and engineered tensions
-
, luciferase assays, RNA isolation, protein purification, qPCR, RNA sequencing, western blotting, and investigation of signaling pathways is desirable. The laboratory is part of the McGowan Institute
-
University, School of Biomedical Engineering, Science and Health Systems Job Summary A laboratory technician position is available in the Biomaterials & Regenerative Medicine Laboratory in the School
-
» Biology Engineering » Biomedical engineering Engineering » Biomaterial engineering Researcher Profile Recognised Researcher (R2) Established Researcher (R3) Country Spain Application Deadline 3 Jun 2024
-
and biomaterials as therapeutics and devices. Project: RNA medicines have gained considerable momentum in the past few years with the approval of Onpattro and the COVID-19 messenger RNA vaccines. While
-
biomaterials (tissues and primary cells) from patients with PKD and normal controls, and the use of genetically modified mice with renal cystic disease. The laboratory also maintains repositories or Biobanks
-
interest lies at the interface of RNA/DNA/protein chemistry and engineering, immunology, and applied chemistry and biomaterials. Our current focus is to develop nucleic acid immunotherapeutic/vaccines and
-
circular RNAs, to tackle unmet medical challenges such as sepsis which is responsible for 1 in 5 deaths worldwide. This project aims to develop novel biomaterials and nano-sized particles to deliver circRNAs
-
approaches: viral vectors for gene therapy, bioengineering for biomaterials or regenerative medicine approaches, and the biology/bioengineering interface for alpha-therapy using vectorized internal